Hard2 marksMultiple Choice
Financial ReportingSection BConsolidationRetained Earnings

ACCA · Question 30 · Financial Reporting

Section B - Case 3: BioHealth Holdings

BioHealth's retained earnings at 31 December 20X8 were $14,000,000. MedTech's retained earnings at acquisition were $4,000,000 and at 31 December 20X8 were $5,200,000. BioHealth sold goods to MedTech resulting in a PURP of $40,000. An impairment review at year-end determined that goodwill had been impaired by $100,000. (NCI is valued at fair value).

What is the Consolidated Retained Earnings balance as at 31 December 20X8?

Answer options:

A.

$14,860,000

B.

$14,785,000

C.

$14,760,000

D.

$14,825,000

How to approach this question

Start with Parent's RE. Add Parent's share of Sub's post-acquisition RE. Deduct PURP (since Parent is the seller). Deduct Parent's share of goodwill impairment (since NCI is at fair value, impairment is split).

Full Answer

B.$14,785,000✓ Correct
BioHealth's own retained earnings = $14,000,000. BioHealth's share of MedTech's post-acquisition retained earnings = 75% × ($5,200,000 - $4,000,000) = $900,000. Less: PURP (BioHealth is the seller, so it bears 100% of the adjustment) = ($40,000). Less: Share of goodwill impairment. Since NCI is at fair value, impairment is shared. Parent share = 75% × $100,000 = ($75,000). Consolidated Retained Earnings = $14,000,000 + $900,000 - $40,000 - $75,000 = $14,785,000.

Common mistakes

Deducting 100% of the goodwill impairment from the parent's retained earnings when the fair value method is used for NCI.

Practice the full ACCA FR — Financial Reporting Practice Exam 6

32 questions · hints · full answers · grading

More questions from this exam